Proposed Data Collections Submitted for Public Comment and Recommendations, 46200-46201 [E9-21675]

Download as PDF 46200 Federal Register / Vol. 74, No. 172 / Tuesday, September 8, 2009 / Notices communication channels, for influencing behavior change. It helps researchers identify and understand the characteristics—interests, behaviors and needs—of target populations that influence their decisions and actions. Formative research is integral in developing programs as well as improving existing and ongoing programs. Formative research also looks at the community in which an intervention is being or planning to be implemented and helps the project staff understand the interests, attributes and needs of different populations and persons in their community. Formative research is research that occurs before a program is designed and implemented, or while a program is being conducted. Formative research is an integral part of developing programs or adapting programs that deal with the complexity of behaviors, social context, cultural identities, and health care that underlie the epidemiology of HIV/AIDS, viral hepatitis, STDs, and TB in the U.S. CDC conducts formative research to develop public-sensitive communication messages and userfriendly tools prior to developing or recommending interventions, or care. Sometimes these studies are entirely behavioral but most often they are cycles of interviews and focus groups designed to inform the formation of a product. Short term qualitative interviewing and cognitive research techniques have previously proven invaluable in the development of scientifically valid and populationappropriate methods, interventions, and instruments. Products from the proposed studies will be used for sustainable projects for HIV/AIDS, Sexually Transmitted Infections (STI), viral Hepatitis, and Tuberculosis prevention that are presented as evidence to disease specific National Advisory Committees, in order to support revisions to existing prevention and intervention methods, and provide new recommendations which cannot be developed without formative research. This request includes studies investigating the utility and acceptability of proposed recruitment methods, intervention contents and delivery, questionnaire domains, individual questions, and interactions with project staff or electronic data collection equipment. These activities will also provide information about how respondents answer questions and ways in which question response bias and error can be reduced. Overall, these development activities are intended to provide information that will increase the success of the surveillance or research project through increasing response rates and decreasing response error thereby decreasing future data collection burden to the public. The studies that will be covered under this request will include one or more of the following investigational modalities: (1) Focus group and individual interviews; (2) Cognitive interviews for development and testing of specific data collection instruments; (3) Component testing of instruments developed from qualitative research or communication methods; (4) testing of behavioral interventions; (5) public acceptance of intervention and prevention methods; (6) utilizing computer-assisted instruments (including web-based technology). The implementors may be health jurisdictions, non-governmental organizations including academia, forprofit contractors, private health care facilities, pharmacies, or a combination of these agencies. Respondents who will participate in individual and group interviews (qualitative, cognitive, and computerassisted development activities) are selected purposely from those who respond to recruitment advertisements. In addition to utilizing advertisements for recruitment, respondents who will participate in research on survey methods may be selected purposively or systematically from within an ongoing surveillance or research project. Participants may be offered cash or gift certificates as tokens of appreciation for participating. CDC estimates that the public will participate in 10 different information collection activities, each lasting between 6–12 months. Participation of respondents is always voluntary and there is no cost to the respondents other than their time. The estimated annual burden hours requested is 46,516 hours. ESTIMATE OF ANNUALIZED BURDEN HOURS Type of respondent General General General General General public public public public public and and and and and health health health health health care care care care care providers providers providers providers providers Number of respondents Form name ....................... ....................... ....................... ....................... ....................... Screener ............................ Consent Forms .................. Individual interview ............ Group interview .................. Individual Survey ............... DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P jlentini on DSKJ8SOYB1PROD with NOTICES Dated: September 2, 2009. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E9–21676 Filed 9–4–09; 8:45 am] [60–Day–09–0741] Centers for Disease Control and Prevention Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and VerDate Nov<24>2008 22:36 Sep 04, 2009 Jkt 217001 PO 00000 Frm 00121 Fmt 4703 Sfmt 4703 Number of responses per respondent 81,200 40,600 6,600 4,000 30,000 1 1 1 1 1 Average burden per response (in hours) 10/60 5/60 1 2 30/60 Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–5960 and send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have E:\FR\FM\08SEN1.SGM 08SEN1 46201 Federal Register / Vol. 74, No. 172 / Tuesday, September 8, 2009 / Notices practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project The Study to Explore Early Development, [OMB# 0920–0741 Exp. 6/30/2010]—Revision—National Center on Birth Defects and Developmental Disabilities (NCBDDD), Centers for Disease Control and Prevention (CDC). The Children’s Health Act of 2000 mandated CDC to establish autism surveillance and research programs to address the number, incidence, correlates, and causes of autism and related disabilities. Under the provisions of this act, CDC funded 5 Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE) including the California Department of Health and Human Services, Colorado Department of Public Health and Environment, Johns Hopkins University, the University of Pennsylvania, and the University of North Carolina at Chapel Hill. CDC National Center on Birth Defects and Developmental Disabilities participates as the 6th CADDRE site. The SEED multi-site, collaborative project is an epidemiological investigation of possible causes for the autism spectrum disorders. Study participants are to be selected from children born in and residing in the following six areas: Atlanta metropolitan area, San Francisco Bay area, Denver metropolitan area, Baltimore metropolitan area, Philadelphia metropolitan area, and Central North Carolina. Children with autism spectrum disorders are compared to children with other developmental problems, referred to as the neurodevelopmentally impaired group (NIC), as well as children who do not have developmental problems, referred to as the subcohort. Data collection methods consist of the following: (1) Medical record review of the child participant; (2) medical record review of the biological mother of the child participant; (3) packets sent to the participants with self-administered questionnaires and a buccal swab kit; (4) a telephone interview focusing on pregnancy-related events and early life history (biological mother and/or primary caregiver interview); (5) a child development evaluation (more comprehensive for case participants than for the control group participants); (6) parent child development interview (for case participants only) administered over the telephone or in-person; (7) a physical exam of the child participant; (8) biological sampling of the child participant (blood and hair); and, (9) biological sampling of the biological parents of the child participant (blood only). Minor changes to some of the self administered questionnaires and the telephone interview include clarification of instructions to the respondent and clarifying specific questions to make the instruments easier to complete and further improve data quality. There is no cost to respondents other than their time. ESTIMATE OF ANNUALIZED BURDEN HOURS Number of respondents Form 1. 2. 3. 4. 5. Number of responses per respondent Average burden per response (in hours) Total burden (in hours) Initial Contact by Mail ................................................................................ Invitation Telephone Contact ..................................................................... Self-administered Questionnaires and buccal sample .............................. Caregiver Interview by telephone .............................................................. Child Clinic Visit (Child Development Evaluation, physical exam, and biosamples) ................................................................................................ Case ....................................................................................................... NIC .......................................................................................................... Subcohort ............................................................................................... 6. Parent Child Development Interview (Case participants only) .................. 7. Parent biosamples ..................................................................................... 9,252 3,886 1,749 1,434 1 1 1 1 10/60 20/60 3 1.5 1,542 1,295 5,247 2,151 1,329 443 443 443 414 1,242 1 1 1 1 1 2 2 2 3 15/60 886 886 886 1242 311 Total ................................................................................................. ........................ .......................... ........................ 14,446 Dated: September 2, 2009. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E9–21675 Filed 9–4–09; 8:45 am] jlentini on DSKJ8SOYB1PROD with NOTICES BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Indian Health Service Request for Public Comment: 60-Day Proposed Information Collection: Indian Health Service Customer Satisfaction Survey AGENCY: ACTION: Indian Health Service, HHS. Notice. SUMMARY: In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 which requires 60-day advance opportunity for public VerDate Nov<24>2008 17:32 Sep 04, 2009 Jkt 217001 PO 00000 Frm 00122 Fmt 4703 Sfmt 4703 comment on proposed information collection projects, the Indian Health Service (IHS) is publishing for comment a summary of a proposed information collection to be submitted to the Office of Management and Budget (OMB) for review. Proposed Collection: Title: 0917– NEW, ‘‘Indian Health Service Customer Satisfaction Survey.’’ Type of Information Collection Request: Threeyear approval of this new information collection, 0917–NEW, ‘‘Indian Health Service Customer Satisfaction Survey.’’ Form(s): Tribal Homeowner Survey, Tribal Partner Survey, Annual Operator Operation and Maintenance (O&M) E:\FR\FM\08SEN1.SGM 08SEN1

Agencies

[Federal Register Volume 74, Number 172 (Tuesday, September 8, 2009)]
[Notices]
[Pages 46200-46201]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-21675]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60-Day-09-0741]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-5960 
and send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance 
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail 
to omb@cdc.gov.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have

[[Page 46201]]

practical utility; (b) the accuracy of the agency's estimate of the 
burden of the proposed collection of information; (c) ways to enhance 
the quality, utility, and clarity of the information to be collected; 
and (d) ways to minimize the burden of the collection of information on 
respondents, including through the use of automated collection 
techniques or other forms of information technology. Written comments 
should be received within 60 days of this notice.

Proposed Project

    The Study to Explore Early Development, [OMB 0920-0741 
Exp. 6/30/2010]--Revision--National Center on Birth Defects and 
Developmental Disabilities (NCBDDD), Centers for Disease Control and 
Prevention (CDC).
    The Children's Health Act of 2000 mandated CDC to establish autism 
surveillance and research programs to address the number, incidence, 
correlates, and causes of autism and related disabilities. Under the 
provisions of this act, CDC funded 5 Centers for Autism and 
Developmental Disabilities Research and Epidemiology (CADDRE) including 
the California Department of Health and Human Services, Colorado 
Department of Public Health and Environment, Johns Hopkins University, 
the University of Pennsylvania, and the University of North Carolina at 
Chapel Hill. CDC National Center on Birth Defects and Developmental 
Disabilities participates as the 6th CADDRE site. The SEED multi-site, 
collaborative project is an epidemiological investigation of possible 
causes for the autism spectrum disorders.
    Study participants are to be selected from children born in and 
residing in the following six areas: Atlanta metropolitan area, San 
Francisco Bay area, Denver metropolitan area, Baltimore metropolitan 
area, Philadelphia metropolitan area, and Central North Carolina. 
Children with autism spectrum disorders are compared to children with 
other developmental problems, referred to as the neurodevelopmentally 
impaired group (NIC), as well as children who do not have developmental 
problems, referred to as the subcohort.
    Data collection methods consist of the following: (1) Medical 
record review of the child participant; (2) medical record review of 
the biological mother of the child participant; (3) packets sent to the 
participants with self-administered questionnaires and a buccal swab 
kit; (4) a telephone interview focusing on pregnancy-related events and 
early life history (biological mother and/or primary caregiver 
interview); (5) a child development evaluation (more comprehensive for 
case participants than for the control group participants); (6) parent 
child development interview (for case participants only) administered 
over the telephone or in-person; (7) a physical exam of the child 
participant; (8) biological sampling of the child participant (blood 
and hair); and, (9) biological sampling of the biological parents of 
the child participant (blood only). Minor changes to some of the self 
administered questionnaires and the telephone interview include 
clarification of instructions to the respondent and clarifying specific 
questions to make the instruments easier to complete and further 
improve data quality.
    There is no cost to respondents other than their time.

                                       Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                    Number of     Average burden
                      Form                          Number of     responses per     per response   Total burden
                                                   respondents      respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
1. Initial Contact by Mail.....................           9,252                1           10/60           1,542
2. Invitation Telephone Contact................           3,886                1           20/60           1,295
3. Self-administered Questionnaires and buccal            1,749                1               3           5,247
 sample........................................
4. Caregiver Interview by telephone............           1,434                1             1.5           2,151
5. Child Clinic Visit (Child Development                  1,329
 Evaluation, physical exam, and biosamples)....
    Case.......................................             443                1               2             886
    NIC........................................             443                1               2             886
    Subcohort..................................             443                1               2             886
6. Parent Child Development Interview (Case                 414                1               3            1242
 participants only)............................
7. Parent biosamples...........................           1,242                1           15/60             311
                                                ----------------------------------------------------------------
        Total..................................  ..............  ...............  ..............          14,446
----------------------------------------------------------------------------------------------------------------


    Dated: September 2, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. E9-21675 Filed 9-4-09; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.